![Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2- VASc Risk Factor Be Anticoagulated? | Stroke Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2- VASc Risk Factor Be Anticoagulated? | Stroke](https://www.ahajournals.org/cms/asset/fa1580af-476b-41f1-9082-d626262c9a1f/1831fig01.jpeg)
Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2- VASc Risk Factor Be Anticoagulated? | Stroke
![CHADS 2 -> CHA 2 DS 2 VASc. CHA2DS2-VASc Risk Score CHF or LVEF < 40% 1 Hypertension1 Age > 752 Diabetes1 Stroke/TIA/ Thromboembolism 2 Vascular Disease. - ppt download CHADS 2 -> CHA 2 DS 2 VASc. CHA2DS2-VASc Risk Score CHF or LVEF < 40% 1 Hypertension1 Age > 752 Diabetes1 Stroke/TIA/ Thromboembolism 2 Vascular Disease. - ppt download](https://images.slideplayer.com/30/9547440/slides/slide_2.jpg)
CHADS 2 -> CHA 2 DS 2 VASc. CHA2DS2-VASc Risk Score CHF or LVEF < 40% 1 Hypertension1 Age > 752 Diabetes1 Stroke/TIA/ Thromboembolism 2 Vascular Disease. - ppt download
![Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk](https://www.ahajournals.org/cms/asset/7bec410e-c520-40c2-89c4-c06d4349106e/e003476fig03.jpg)
Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk
![Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation? - ScienceDirect Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109714073914-gr2.jpg)
Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation? - ScienceDirect
CHA2DS2-VASc score as an independent outcome predictor in patients hospitalized with acute ischemic stroke | PLOS ONE
Use of CHADS2 and CHA2DS2-VASc Scores to Predict Subsequent Myocardial Infarction, Stroke, and Death in Patients with Acute Coronary Syndrome: Data from Taiwan Acute Coronary Syndrome Full Spectrum Registry | PLOS ONE
Use of CHADS2 and CHA2DS2-VASc Scores to Predict Subsequent Myocardial Infarction, Stroke, and Death in Patients with Acute Coronary Syndrome: Data from Taiwan Acute Coronary Syndrome Full Spectrum Registry | PLOS ONE
CHA2DS2-VASc score as an independent outcome predictor in patients hospitalized with acute ischemic stroke | PLOS ONE
![Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study | The BMJ Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study | The BMJ](https://www.bmj.com/content/bmj/342/bmj.d124/F2.large.jpg)
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study | The BMJ
![CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation - The American Journal of Medicine CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation - The American Journal of Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/dc93ddbe-1553-443d-ac12-8d0b5724d208/gr1.jpg)